Were the Panels Correct?: Policy Analysis of Breast and Cervical Cancer Guideline Changes |
From inside the book
Try this search over all volumes: _ Appendix
Results 1-0 of 0
Contents
Guidelines Past and Present | 5 |
Utilization and Need | 19 |
Insurance Coverage for Screenings | 23 |
Copyright | |
16 other sections not shown
Common terms and phrases
Actual Cancer 0.04 Actual Positive 94 Adjuvant Chemotherapy 100 Agency for Healthcare American Cancer Society Breast and Cervical Breast Cancer Screening Breast Conservation Surgery Cervical Cancer Control cervical cancer screening Clinical Breast Exam Colposcopy Congress of Obstetricians Conization Death Department of Community Detection 0.2 Early Detection Emotional Toll 100 Expected Value Amount False Positive-Confirmed Force Recommendation Statement Guidelines Discount rate Gynecologists Healthcare Research Hormone Therapy 100 HPV DNA test HPV Test Human Papillomavirus Hysterectomy independent CBA Kaiser Family Foundation Loss of Productivity/Income Michigan Department Michigan women MRM with Reconstruction National Cancer Institute Net Present Value Number Obstetricians and Gynecologists Pap Smear Pap Test Positive 93 Positive-Confirmed via Biopsy Present Value Preventive Services Task Price Expected Value Productivity/Income 100 QALYs Quality Screening Radiation 100 Research and Quality risk Screening for Breast Services Task Force Tamoxifen Hormone Therapy TOTAL GRAND TOTAL U.S. Preventive Services USPSTF and ACOG Value Amount Tested